Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study.
作者信息
Xiong Jianping, Wang Yaqin, Chen Guang, Jin Long
机构信息
Interventional Radiology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China.
Department of Interventional Radiology, China Medical University First Hospital, Shenyang, China.
出版信息
Gut. 2020 Dec;69(12):2265-2267. doi: 10.1136/gutjnl-2020-321052. Epub 2020 Apr 9.
Abstract
摘要
相似文献
1
Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study.质子泵抑制剂与胆囊癌风险：一项基于医院的病例对照研究。
Gut. 2020 Dec;69(12):2265-2267. doi: 10.1136/gutjnl-2020-321052. Epub 2020 Apr 9.
2
Proton pump inhibitors and gastric cancer: a population-based cohort study.质子泵抑制剂与胃癌：一项基于人群的队列研究。
Gut. 2022 May;71(5):1039-1041. doi: 10.1136/gutjnl-2021-325385. Epub 2021 Jul 14.
3
Proton pump inhibitors and risk of gastric cancer in a case-control study.一项病例对照研究中的质子泵抑制剂与胃癌风险
Gut. 2019 Apr;68(4):765-767. doi: 10.1136/gutjnl-2018-316371. Epub 2018 Apr 16.
4
Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.在一例无幽门螺杆菌感染病史的病例中，胃增生性息肉与质子泵抑制剂的使用相关。
Intern Med. 2017;56(14):1825-1829. doi: 10.2169/internalmedicine.56.8040. Epub 2017 Jul 15.
5
Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.质子泵抑制剂会增加胆囊炎风险：一项基于人群的病例对照研究。
Gut. 2019 Jul;68(7):1337-1339. doi: 10.1136/gutjnl-2018-316899. Epub 2018 Jul 17.
6
Haemorrhagic gastric hyperplastic polyps associated with long-term use of proton pump inhibitor in a case without Helicobacter pylori infection.在一例无幽门螺杆菌感染的病例中，与长期使用质子泵抑制剂相关的出血性胃增生性息肉
J Clin Pharm Ther. 2019 Jun;44(3):493. doi: 10.1111/jcpt.12819. Epub 2019 Feb 17.
7
OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.OLGIM分期和质子泵抑制剂的使用可预测胃癌风险。
Gut. 2022 May;71(5):1043-1044. doi: 10.1136/gutjnl-2021-325551. Epub 2021 Aug 3.
8
eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.根除治疗失败可能混淆了近期一项大规模健康数据库研究的结果，该研究显示质子泵抑制剂会增加胃癌风险。
Gut. 2018 Nov;67(11):2071-2072. doi: 10.1136/gutjnl-2017-315698. Epub 2017 Dec 15.
9
Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for : a retrospective cohort analysis.长期使用质子泵抑制剂是治疗后患胃癌的一个风险因素：一项回顾性队列分析。
Gut. 2018 Oct;67(10):1908-1910. doi: 10.1136/gutjnl-2017-315710. Epub 2017 Dec 22.
10
Long-term proton pump inhibitor use after eradication may create a gastric environment for -nitrosamine formation and gastric cancer development.根除幽门螺杆菌后长期使用质子泵抑制剂可能会为亚硝胺的形成和胃癌的发展创造一个胃部环境。
Gut. 2019 Jun;68(6):1131. doi: 10.1136/gutjnl-2018-316592. Epub 2018 May 25.
引用本文的文献
1
Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance.质子泵抑制剂与口腔-肠道微生物群：从作用机制到临床意义
Biomedicines. 2024 Oct 7;12(10):2271. doi: 10.3390/biomedicines12102271.
2
Individualized prevention of proton pump inhibitor related adverse events by risk stratification.通过风险分层对质子泵抑制剂相关不良事件进行个体化预防。
Nat Commun. 2024 Apr 27;15(1):3591. doi: 10.1038/s41467-024-48007-8.
3
Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis.使用质子泵抑制剂会增加肝胆胰癌症的风险。一项系统评价与荟萃分析。
Front Pharmacol. 2022 Sep 14;13:979215. doi: 10.3389/fphar.2022.979215. eCollection 2022.
4
Hepatitis B and C virus infections and the risk of biliary tract cancers: a meta-analysis of observational studies.乙型和丙型肝炎病毒感染与胆道癌风险：观察性研究的荟萃分析
Infect Agent Cancer. 2022 Aug 27;17(1):45. doi: 10.1186/s13027-022-00457-9.
5
Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants.经常使用胃酸抑制剂与后续胆结石风险之间的关联：一项对47万名参与者的前瞻性队列研究。
Front Pharmacol. 2022 Jan 28;12:813587. doi: 10.3389/fphar.2021.813587. eCollection 2021.
本文引用的文献
1
Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data.解读与使用质子泵抑制剂相关的报告风险：基于国家门诊数据的10年分析中的残余混杂因素
Gastroenterology. 2020 Feb;158(3):780-782.e3. doi: 10.1053/j.gastro.2019.10.023. Epub 2019 Oct 31.
2
Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.质子泵抑制剂会增加胆囊炎风险：一项基于人群的病例对照研究。
Gut. 2019 Jul;68(7):1337-1339. doi: 10.1136/gutjnl-2018-316899. Epub 2018 Jul 17.
3
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.血管事件后长期抗血小板治疗中出血的年龄特异性风险、严重程度、病程及结局：一项基于人群的队列研究
Lancet. 2017 Jul 29;390(10093):490-499. doi: 10.1016/S0140-6736(17)30770-5. Epub 2017 Jun 13.
4
Proton pump inhibitors affect the gut microbiome.质子泵抑制剂会影响肠道微生物群。
Gut. 2016 May;65(5):740-8. doi: 10.1136/gutjnl-2015-310376. Epub 2015 Dec 9.
5
Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: a nationwide observational study.尽管采取了干预措施，但基层医疗中质子泵抑制剂的处方量仍在迅速增加：一项全国性观察性研究。
Eur J Gen Pract. 2014 Dec;20(4):290-3. doi: 10.3109/13814788.2014.905535. Epub 2014 Apr 29.
6
Peptic ulcer disease.消化性溃疡病
Lancet. 2009 Oct 24;374(9699):1449-61. doi: 10.1016/S0140-6736(09)60938-7. Epub 2009 Aug 13.
7
Clinical practice. Gastroesophageal reflux disease.临床实践。胃食管反流病。
N Engl J Med. 2008 Oct 16;359(16):1700-7. doi: 10.1056/NEJMcp0804684.
8
Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy.原发性胆囊癌：危险因素的识别及预防性胆囊切除术的作用
Am J Gastroenterol. 2000 Jun;95(6):1402-10. doi: 10.1111/j.1572-0241.2000.02070.x.
9
Omeprazole induces altered bile acid metabolism.奥美拉唑会导致胆汁酸代谢改变。
Gut. 1998 Feb;42(2):266-71. doi: 10.1136/gut.42.2.266.
Zotero 插件